A Tuberculosis Breakthrough — Finally
The world is long overdue for a better treatment. Tuberculosis is still one of the leading causes of death because existing treatments are inadequate, especially against drug-resistant forms of the disease. Improvement efforts have been stalled for decades, so it’s a big deal that earlier this year, scientists announced that a new TB treatment regimen proved effective in early-phase research. From here, the drug regimen must go through a large clinical trial, but if it pans out, it could dramatically reduce the time required to cure drug-resistant TB while saving poor countries billions in health care costs.